Investment Pitches

Pitch Summary:
Bolloré was a detractor for the quarter but the underlying thesis is very much intact. Just a few years ago, Bolloré was a complicated conglomerate that had high leverage, an African port and logistics company, a European freight forwarding company, ownership in Vivendi SE, and ownership in Universal Music Group N.V. Today, the company has simplified its holdings to Vivendi and Universal Music Group plus significant net cash on the balance sheet from the sale of non-media assets. Universal Music group continues to be a strong component of value, and it is expected to be listed in the U.S. later this year or early next year. We believe that Bolloré's net asset value (NAV) is worth mid-teens, and with the current share price in the mid-single digits, the investment represents an extremely attractive value. Meanwhile, the company continues to make moves to further simplify its structure.

BSD Analysis:
Yacktman maintains conviction in Bollore despite recent underperformance, viewing the company as a successful transformation story from complex conglomerate to focused media holding company. The fund highlights Bollore's dramatic simplification over recent years, divesting African ports, logistics operations, and freight forwarding businesses to focus on high-quality media assets through Vivendi and Universal Music Group. This restructuring has generated significant net cash while eliminating the complexity discount that previously weighed on valuation. The manager sees substantial value in Universal Music Group, particularly with an anticipated U.S. listing that should unlock value through improved liquidity and multiple expansion. Yacktman's NAV analysis suggests the stock trades at a significant discount, with shares in the mid-single digits versus estimated fair value in the mid-teens. The ongoing structural simplification provides additional upside as management continues to optimize the portfolio. This represents a classic sum-of-the-parts opportunity where asset sales and corporate restructuring should drive meaningful value realization for patient investors.

Pitch Summary:
Samsung has been a solid contributor to performance after having detracted from results last year. The company announced its first design win with Nvidia for high bandwidth memory (HBM) chips this quarter. Samsung was late to the artificial intelligence (AI) party, and this milestone validates its position in the HBM chip market. Memory chips can be found in a vast array of end products, from data center servers to automobiles and refrigerators. There is a finite production capacity for dynamic random-access memory (DRAM) and a small number of players who can provide these components. Samsung remains a leader in semiconductor fabrication and benefits from its locations that are not in Taiwan (South Korea and Texas). Samsung is also enjoying tailwinds from the continued regulatory improvements in South Korea, a trend that we believe will continue to unfold as governance and market access improve.

BSD Analysis:
Yacktman presents a compelling turnaround thesis for Samsung Electronics, highlighting the company's recovery from previous underperformance through strategic positioning in the AI semiconductor market. The fund emphasizes Samsung's recent design win with Nvidia for high bandwidth memory chips as validation of its competitive position in the critical HBM market. The manager appreciates Samsung's geographic diversification advantage with fabrication facilities in South Korea and Texas, reducing Taiwan concentration risk that affects many semiconductor peers. The investment thesis is strengthened by Samsung's oligopolistic position in DRAM manufacturing, where finite production capacity and limited competitors create pricing power. Additionally, Yacktman identifies ongoing regulatory improvements in South Korea as a structural tailwind that should enhance corporate governance and market access. The fund views Samsung as well-positioned to capitalize on the AI infrastructure buildout while benefiting from improved domestic regulatory environment. This represents a classic Yacktman value play where temporary setbacks have created an attractive entry point in a fundamentally strong franchise.

Pitch Summary:
Medtronic is a leading medical device company developing therapeutic devices for chronic diseases. It is an innovative organization, often reaching market first with differentiated technology across pacemakers, heart valves, insulin pumps and surgical tools. New CEO Geoff Martha has refocused the company after years of depressed returns following the expensive Covidien acquisition, bringing fresh leadership and concentrating R&D on highest-growth areas like renal denervation for hypertension and pulsed field ablation for atrial fibrillation. The planned spin-off of the diabetes business fits with management's effort to focus on highest-margin growth drivers where Medtronic has core competencies. Through disciplined capital allocation and operating efficiencies, Medtronic should leverage 5-6% organic growth into high single or low double-digit earnings growth. With an earnings yield of 5%, the shares appear undervalued.

BSD Analysis:
The manager views Medtronic as a turnaround story under new leadership, with CEO Geoff Martha implementing strategic focus after years of underperformance following the Covidien acquisition. The company's innovation track record and first-to-market capabilities across multiple device categories provide a strong competitive foundation. Management's strategic refocusing on high-growth areas like renal denervation and pulsed field ablation, combined with the planned diabetes business spin-off, should improve operational efficiency and capital allocation. The leverage potential is attractive—5-6% organic growth translating to high single or low double-digit earnings growth through operational improvements. At a 5% earnings yield, the valuation appears compelling for a leading medical device company with improving fundamentals and strategic clarity. The manager sees this as an opportunity to acquire a quality healthcare franchise during a period of strategic transition at an attractive valuation.

Pitch Summary:
H World Group, China's largest private hotel operator with over 12,000 hotels and one million rooms, operates a pioneering "manachised" model that delivers exceptional unit economics. Under this structure, H World retains operational control by appointing each hotel's general manager, while franchisees carry operating costs and property owners fund development. This model generates 22% operating margins for H World, with franchisees having three- to five-year payback periods and the lowest development and operating costs per room in the market. The company's competitive moat comes from supply chain scale, a loyalty program generating 60% direct bookings and proprietary technology that enables self-service hotels to operate with minimal staff. H World targets two million rooms in the medium term, representing low-teens annual growth as China's branded hotel penetration increases from 40% toward the 70% seen in developed markets. The company is capturing share from inefficient state-owned chains and repositioning toward higher-margin midscale and upscale segments to meet demand from China's emerging middle class. The valuation is striking: the stock trades near 2020 levels, while revenue and operating earnings have doubled. H World generates over $1 billion in EBITDA, comparable to Hyatt and InterContinental, yet carries an enterprise value below $12 billion versus $19-23 billion for those peers.

BSD Analysis:
The manager identifies H World's "manachised" model as a unique competitive advantage that optimizes capital allocation and operational efficiency. The structure generates superior unit economics—22% operating margins for H World while providing attractive returns for franchisees—creating a win-win dynamic that supports rapid expansion. The company's competitive moat appears sustainable, built on supply chain scale, direct booking capabilities (60% through loyalty programs), and proprietary technology enabling minimal staffing. The growth runway is substantial, targeting two million rooms as China's branded hotel penetration increases from 40% to 70%, while simultaneously capturing share from inefficient state-owned competitors. The valuation disconnect is compelling: H World trades near 2020 levels despite doubled revenue and earnings, with an enterprise value significantly below comparable international peers despite similar EBITDA generation. The manager views this as an opportunity to acquire a dominant market leader at a significant discount during a period of market pessimism toward Chinese assets.

Pitch Summary:
Elutia Inc. (ELUT) was a detractor from performance during the quarter. Elutia is a medical device company that produces a biologic envelope to hold cardiac devices (CIED) in place beneath the skin. These devices are typically implanted near the shoulder and have issues with migration (moving beneath the skin). Elutia developed a biologic form of these devices versus plastic versions that are produced by Medtronic. We thought they would sell the whole company to Boston Scientific as they compete directly with Medtronic. Unfortunately, management sold the product to Boston Scientific for only $88 million, far less than what we and they would have expected they would get for it. Management has made the decision to use the money to develop unapproved products to the detriment of shareholders. We had expected a purchase price of over $200 million. While it was a small position across portfolios, it is disappointing, nonetheless. We sold the remaining holdings of ELUT on this news.

BSD Analysis:
The manager expresses clear disappointment with Elutia's management decisions and strategic execution. The company developed a competitive biologic alternative to Medtronic's plastic cardiac device envelopes, addressing device migration issues. However, management significantly undermonetized this asset by selling to Boston Scientific for only $88 million versus the manager's $200+ million expectation. The decision to redirect proceeds toward unapproved product development rather than returning value to shareholders demonstrates poor capital allocation. This represents a classic case of management destroying shareholder value through suboptimal strategic decisions. The manager's complete exit reflects lost confidence in management's ability to maximize shareholder returns. The investment thesis was sound but execution risk materialized through poor deal-making.

Pitch Summary:
BYD, the global leader in electric and hybrid vehicles, delivered 4.3 million units in 2024, not far from Tesla's 1.8 million and Toyota's 10 million, a remarkable acceleration from just 600,000 units in 2021. The company's competitive advantage stems from something rare in the automotive industry: deep vertical integration. While traditional manufacturers rely on fragmented supplier networks, BYD designs and manufactures key components in-house, from batteries to semiconductors. This isn't just about control; it's about fundamental cost advantage. As the world's largest mobile battery maker before entering autos, founder Wang Chuan-Fu envisioned EVs as "batteries on wheels" and built the company to exploit the structural simplicity of electric drivetrains, which require fewer than 50 components versus 1,200+ in internal combustion engines. The result is a 15-25% cost advantage over legacy automakers, allowing BYD to offer compelling value while maintaining margins not far from Toyota levels. The company commands 35% of China's EV market and 30% of its battery market, with successful expansion underway in South Asia and Latin America. Europe is next. The stock trades at over 7% normalized earnings yield despite double-digit growth potential, as the stock price consolidated while price competition temporarily pressures margins.

BSD Analysis:
The manager highlights BYD's exceptional vertical integration as a sustainable competitive advantage in the rapidly evolving EV market. The company's evolution from battery manufacturer to automotive leader demonstrates strategic foresight, with founder Wang Chuan-Fu's vision of EVs as "batteries on wheels" proving prescient. BYD's 15-25% cost advantage over legacy automakers, derived from in-house component manufacturing, provides significant pricing flexibility and margin protection. The scale achievement is remarkable—4.3 million units delivered in 2024 versus 600,000 in 2021, approaching Tesla and Toyota volumes. Market dominance in China (35% EV share, 30% battery share) provides a strong foundation for international expansion. At over 7% normalized earnings yield with double-digit growth potential, the valuation appears compelling despite temporary margin pressure from price competition. The manager views current weakness as a consolidation opportunity rather than fundamental deterioration.

Pitch Summary:
Alibaba is one of China's digital infrastructure backbones, a $150 billion revenue company that has evolved from Jack Ma's startup into the dominant force in Chinese e-commerce and cloud computing. The company commands 45% of China's e-commerce market through Taobao and Tmall, platforms that connect 10 million merchants with one billion customers. After years of competitive pressure from JD.com and Pinduoduo, Alibaba's market position has stabilized, and its scale enables high-margin operations while taking less from merchants than competitors. The regulatory environment has shifted dramatically since 2023, with Beijing moving from crackdown to active support, explicitly endorsing Alibaba's aggressive capital return plans of 117 billion CNY in 2025 backed by 500 billion CNY in net cash. What makes Alibaba particularly compelling is how its cloud business is accelerating. Holding an estimated 30% of China's cloud market, the company seamlessly integrates its Qwen LLM into the e-commerce ecosystem, attracting businesses to its cloud infrastructure while delivering practical AI applications. With 100,000 corporate clients already using Qwen, and China's cloud penetration still far below Western markets, the runway is substantial. The stock trades at an 8% earnings yield despite this combination of stable e-commerce cash generation and high-growth cloud potential.

BSD Analysis:
The manager presents a compelling bull case for Alibaba centered on its dominant market position and AI-driven cloud acceleration. With 45% market share in Chinese e-commerce and stabilizing competitive dynamics, Alibaba has demonstrated pricing power and operational leverage. The regulatory shift from crackdown to support, evidenced by Beijing's endorsement of aggressive capital returns, removes a key overhang. The cloud business acceleration through Qwen LLM integration represents a significant catalyst, with 100,000 corporate clients already adopted and substantial runway given China's low cloud penetration versus Western markets. At an 8% earnings yield, the valuation appears attractive for a company combining stable cash generation with high-growth cloud potential. The manager's timing appears opportunistic, acquiring shares during a period of market skepticism despite improving fundamentals and regulatory tailwinds.

Pitch Summary:
Zeta Global Holdings Corp. (ZETA) is a marketing technology software company which benefits from multiple market tailwinds in the advertising industry. Zeta's software platform combined with artificial intelligence helps companies' market more efficiently by targeting ads based on specific demographics. The Zeta marketing platform helps customers deliver advertisements through all channels such as email, social media, web, chat, connected TV and video. Zeta is unique in that their platform doesn't use cookies. This reduces risk from a regulatory and customer standpoint as they are not impacted by these issues. Consequently, they can take market share from competitors like Adobe, Salesforce, and Oracle, who have all made legacy acquisitions to enter the space at valuations of 8-20x EV/Revenues. ZETA trades for 3x EV/Revenues. Oracle announced they would be exiting the advertising business on their Q4 2024 earnings call, creating an incremental revenue opportunity for Zeta. Despite the broader softness in software spending, Zeta remains unaffected, citing a healthy demand environment. The company was founded by former Apple CEO, John Scully, and the management team has a strong track record of performance (the company has beaten their revenue guidance for 16 consecutive quarters since their IPO in 2021). Zeta's stock has been volatile throughout the past few months as investors digested a short report in November. As noted above Zeta trades at a significant discount to peers in the software industry at only 3x EV/Revenues vs. 5-7x for the group, despite stronger growth and operating margins.

BSD Analysis:
The manager presents a compelling value opportunity in Zeta Global based on competitive advantages and attractive valuation. The company's cookie-free platform provides regulatory protection and competitive differentiation versus legacy players like Adobe, Salesforce, and Oracle. This positioning enables market share gains as competitors face regulatory headwinds. The valuation appears deeply discounted at 3x EV/Revenue compared to peers at 5-7x and competitors at 8-20x, despite superior growth and margins. Oracle's exit from advertising creates additional market opportunity. Management's exceptional track record of beating guidance for 16 consecutive quarters demonstrates strong execution capability. While recent volatility from a short report has created near-term pressure, the fundamental thesis remains intact with healthy demand despite broader software spending weakness.

Pitch Summary:
Xeris Pharmaceuticals Inc. (XERS) is a specialty pharmaceutical company with unique products serving large unmet medical needs. Their main product includes Recorlev which is a medication prescribed for the treatment of Cushing's Syndrome (CS). CS is a serious medical condition where out of control cortisol levels wreak havoc on the body, leading to fatigue, weight gain, and hypertension. XERS recently hosted an Investor Day presentation where they announced a 2030 model of $750 million in revenue from the current portfolio, particularly Recorlev. For reference, the total company is expected to generate $285 million in 2025. The gross margins for Recorlev are around 80% and profitability is expected to ramp significantly in the coming years as the company leverages the investments they've already made. Xeris expanded their salesforce by an additional 40 reps in November of 2024. Those reps are now contributing to the 54% quarterly revenue growth XERS achieved in the 2nd quarter. This is an acceleration from Q1 where they grew 44% year over year. While the stock has almost doubled since June when we bought it, we continue to hold it in investor portfolios due to the large opportunity ahead.

BSD Analysis:
The manager maintains a strong bull thesis on Xeris despite significant gains since their June purchase. The investment centers on Recorlev, a treatment for Cushing's Syndrome with compelling unit economics including 80% gross margins. Management's 2030 revenue target of $750 million represents substantial growth from the expected $285 million in 2025, indicating a multi-year growth runway. Recent sales force expansion is already showing results with accelerating quarterly growth from 44% to 54% year-over-year. The company appears to be reaching an inflection point where prior investments begin generating meaningful profitability. Despite the stock doubling, the manager's conviction remains high given the large addressable market opportunity and strong execution trajectory.

Pitch Summary:
MDxHealth (MDXH) is a prostate cancer diagnostics screening company we initially purchased at around $2 per share a year ago. Prostate is the second most diagnosed cancer type overall and the most common in men. Their portfolio includes Select mdx, Confirm mdx, Genomic Prostate Score (GPS), and the hereditary prostate cancer test. The company has a network of over 7 thousand physicians and has completed over 250 thousand tests in total. With their series of non-invasive tests, they offer physicians and patients additional guidance when making treatment decisions. MDXH has grown revenue each of the last 12 quarters at over 20% and we believe they can accelerate that rate as they recently acquired an additional prostate test. Despite the positive momentum the stock only trades at 2x EV/Revenues vs. peers at 5-9x for similar growth and margin profiles.

BSD Analysis:
The manager presents a compelling bull case for MDxHealth based on strong fundamentals and attractive valuation. The company operates in the large prostate cancer diagnostics market with a comprehensive test portfolio and established physician network of 7,000+ doctors. Revenue growth has been consistently strong at 20%+ for 12 consecutive quarters, with potential for acceleration following a recent acquisition. The valuation appears deeply discounted at 2x EV/Revenue compared to peers trading at 5-9x despite similar growth profiles. The non-invasive nature of their tests addresses a clear medical need in treatment decision-making. The manager's entry point around $2 per share suggests significant appreciation potential given the growth trajectory and valuation gap.

Pitch Summary:
Founded in 1949 in Herzogenaurach, Germany, Adidas was the vision of Adolf "Adi" Dassler, who split from his brother Rudolf (the founder of Puma) to create what would become one of the world's most enduring sports brands. Registered under the now-iconic three stripes trademark, Adidas quickly rose to prominence when West German footballers wore its innovative boots to victory in the 1954 FIFA World Cup, a defining moment that cemented its reputation for high-performance sportswear on the global stage. In the decades since, Adidas has expanded far beyond football boots, entering running, basketball and training categories. Along the way, it has pioneered innovations such as screw-in studs and various cushioning and ultra-lightweight footwear and clothing materials. The brand's visibility at the Olympic Games, World Cups and global running events has deepened its association with sporting excellence. In more recent decades, the blending of sports and lifestyle has broadened the company's addressable market as athletic apparel and footwear have become everyday wear. Adidas was pivotal to the history of "athleisure" wear, introducing the tracksuit to non-athletes all the way back in the 1970s. Today, Adidas is the world's #2 player in athletic footwear and apparel, behind category leader Nike. Despite multiple new entrants across different sporting verticals and niches, these brands continue to dominate sportswear on the global stage and generate annual revenues 5x and 3x larger than the third-largest brand, Puma. While strong economic moats can be difficult to find in competitive consumer categories such as apparel and footwear, we continue to believe the brand equity, marketing reach, R&D capabilities and global distribution networks of the world's two leading sportswear brands provide meaningful and durable advantages. Importantly, Adidas consistently reinvests to defend these competitive advantages, including an annual marketing budget of around €3 billion – or roughly 12% of net sales. These funds support high-profile partnerships with athletes like Lionel Messi and Patrick Mahomes, sporting teams like Real Madrid and Manchester United, and sporting leagues and events like UEFA Champions League and the Paris Olympics, reinforcing brand visibility and consumer loyalty. While Nike's dominance is strongest in North America and basketball, Adidas holds sway in the world's most popular sport, football, where its unrivalled presence at global events like the upcoming FIFA World Cup acts as a showcase for the brand. Adidas also benefits from an enviable vault of iconic product silhouettes that are now cross-generational staples blending sports and fashion. The brand's most recent global success story, the Adidas Originals Samba sneaker, has roots tracing back to the 1950s and was officially launched in its current form in 1972. Execution is critical in the sportswear industry, where consumer tastes shift quickly. Over decades, Adidas has demonstrated resilience and adaptability through challenging periods. In the last five years alone, the company has navigated a global pandemic, geopolitical backlash in China, an exit from Russia and the winding down of its Yeezy collaboration. These external shocks compressed profitability and ultimately resulted in a CEO change. Under new leadership, the business has regained strong momentum across key markets. From an investment perspective, periods of disruption like this, in categories where structural growth tailwinds and economic moat drivers remain intact, can present attractive investment opportunities. Earlier this year, consumer health and tariff fears drove material underperformance of the apparel and sportswear sector, creating an attractive entry point for Adidas in the Magellan Global Opportunities strategy. While remaining conscious of broader industry risks – including consumer health, fashion cycles, geopolitics, social supply chain and environmental challenges – we believe Adidas represents a compelling long-term opportunity: a brand with deep heritage, durable competitive advantages, and the ability to continue turning global sports tailwinds into sustainable growth.

BSD Analysis:
Magellan presents a compelling bull case for Adidas, emphasizing the company's position as the world's second-largest sportswear brand with durable competitive advantages. The manager highlights Adidas' dominant position in football, the world's most popular sport, contrasting with Nike's strength in basketball and North America. Key competitive moats include substantial marketing investments (€3 billion annually, 12% of sales), iconic brand heritage dating to 1949, and strategic partnerships with elite athletes and sporting events. The investment thesis centers on Adidas' resilience through recent challenges including the pandemic, China backlash, Russia exit, and Yeezy collaboration termination, with new leadership driving momentum recovery. Magellan views the recent sector underperformance as creating an attractive entry point, believing structural growth tailwinds in athleisure and global sports participation remain intact. The manager acknowledges industry risks including consumer health concerns, fashion cycles, and geopolitical challenges but maintains confidence in Adidas' ability to convert sports tailwinds into sustainable growth through its deep heritage and competitive positioning.

Pitch Summary:
Washington H. Soul Pattinson (SOL) is a diversified investment house that we at Airlie see as Australia's own mini-Berkshire Hathaway (the famous investment company led by Warren Buffett). SOL invests its permanent capital for the long term across listed large caps and emerging companies, as well as unlisted property, private equity and private credit. Today it oversees a diversified portfolio (NAV of A$13.2 billion). SOL has a long history, founded in 1903 and originally being a sole operator of pharmacy stores. In the 1960s and 1970s, SOL began to diversify by expanding into the building material and resources sectors through positions in Brickworks and other ASX-listed companies. A key step change to the SOL occurred in 2021 through the acquisition of Milton Corporation, which increased the scale of SOL by c. A$3.7 billion in assets held primarily in domestic equities. Today SOL holds A$13.2 billion in net assets. The SOL investment philosophy focuses on identifying long-term superior risk-adjusted returns, with diversification across industry and asset class to allow the portfolio to weather market cycles and generate sustainable returns. As with Berkshire, the beauty of the model is the permanent capital that SOL controls. The company is not like other fund managers with the risk of capital withdrawal ever present, allowing for true long-term investment decisions. The attractiveness of the SOL investment has only increased by the recent merger with Brickworks. Brickworks and SOL have historically held a long-term cross-shareholding partnership, which saw Brickworks own 26% of SOL and SOL own 43% of Brickworks. The merger not only cleans up the structure of SOL, but following the capital raise to undertake the merger, it leaves SOL with a net cash balance sheet. Since 1 January 2000, SOL has delivered a compound total return of 13.4% p.a., compared with 8.6% p.a. for the S&P/ASX 200 over the same period. While we often compare SOL to Berkshire Hathaway, SOL's returns over this time frame are also ahead of Berkshire's (11.2% p.a. vs. 8.3% p.a. for the S&P 500). Crucially, this outperformance hasn't relied on "high beta" exposures that typically do extremely well in bull markets. SOL's portfolio leans to defensive, cash-generative businesses, which has historically helped it outperform in down markets – a feature we value given today's relatively high market valuations. We maintain a high level of confidence in SOL to continue to undertake high shareholder return investments given the stability and long tenure of key investment personnel. With net cash post-merger, SOL has a green light to pursue accretive investments across its opportunity set. In our view, the combination of permanent capital, a proven team, defensive tilt and a simplified structure positions SOL to continue delivering attractive long-term returns for shareholders.

BSD Analysis:
Airlie presents a compelling bull case for Washington H. Soul Pattinson as Australia's equivalent to Berkshire Hathaway, emphasizing its permanent capital structure and diversified investment approach. The fund highlights SOL's impressive long-term track record, delivering 13.4% annual returns since 2000 versus 8.6% for the ASX 200, while maintaining a defensive portfolio tilt that outperforms in down markets. The recent Brickworks merger is viewed as a significant catalyst, cleaning up the cross-shareholding structure and leaving SOL with a net cash position to pursue new investments. Management quality is emphasized through the long tenure of key personnel, with the CEO having 21 years of experience. The permanent capital model differentiates SOL from traditional fund managers by eliminating redemption risk and enabling true long-term investment decisions. Airlie values the defensive characteristics of SOL's portfolio in the current high-valuation environment. The combination of proven management, simplified structure, and available capital positions SOL for continued outperformance according to the analysis.

Pitch Summary:
Medtronic is a leading medical device company developing therapeutic devices for chronic diseases. It is an innovative organization, often reaching market first with differentiated technology across pacemakers, heart valves, insulin pumps and surgical tools. New CEO Geoff Martha has refocused the company after years of depressed returns following the expensive Covidien acquisition, bringing fresh leadership and concentrating R&D on highest-growth areas like renal denervation for hypertension and pulsed field ablation for atrial fibrillation. The planned spin-off of the diabetes business fits with management's effort to focus on highest-margin growth drivers where Medtronic has core competencies. Through disciplined capital allocation and operating efficiencies, Medtronic should leverage 5-6% organic growth into high single or low double-digit earnings growth. With an earnings yield of 5%, the shares appear undervalued.

BSD Analysis:
The manager identifies Medtronic as an undervalued medical device leader undergoing strategic refocusing under new leadership. CEO Geoff Martha's initiatives to concentrate R&D on high-growth areas like renal denervation and pulsed field ablation should improve returns on invested capital. The planned diabetes business spin-off represents portfolio optimization, allowing management to focus on core competencies and highest-margin growth drivers. Medtronic's innovation track record and first-to-market capabilities across multiple device categories provide sustainable competitive advantages in the medical technology space. The company's ability to leverage 5-6% organic growth into high single or low double-digit earnings growth through operational efficiencies demonstrates operating leverage potential. At a 5% earnings yield, the valuation appears attractive for a market-leading medical device company with improving strategic focus and earnings growth acceleration prospects. The combination of strategic repositioning, innovation capabilities, and compelling valuation creates an attractive investment opportunity in the healthcare technology sector.

Pitch Summary:
H World Group, China's largest private hotel operator with over 12,000 hotels and one million rooms, operates a pioneering "manachised" model that delivers exceptional unit economics. Under this structure, H World retains operational control by appointing each hotel's general manager, while franchisees carry operating costs and property owners fund development. This model generates 22% operating margins for H World, with franchisees having three- to five-year payback periods and the lowest development and operating costs per room in the market. The company's competitive moat comes from supply chain scale, a loyalty program generating 60% direct bookings and proprietary technology that enables self-service hotels to operate with minimal staff. H World targets two million rooms in the medium term, representing low-teens annual growth as China's branded hotel penetration increases from 40% toward the 70% seen in developed markets. The company is capturing share from inefficient state-owned chains and repositioning toward higher-margin midscale and upscale segments to meet demand from China's emerging middle class. The valuation is striking: the stock trades near 2020 levels, while revenue and operating earnings have doubled. H World generates over $1 billion in EBITDA, comparable to Hyatt and InterContinental, yet carries an enterprise value below $12 billion versus $19-23 billion for those peers.

BSD Analysis:
The manager presents a compelling value opportunity in H World based on its unique "manachised" business model and attractive valuation relative to fundamentals. The company's 22% operating margins demonstrate the efficiency of its hybrid franchise structure, where H World maintains operational control while franchisees bear costs. The competitive moat appears sustainable through supply chain scale, 60% direct booking loyalty program, and proprietary technology enabling minimal staffing. The growth runway is substantial, targeting two million rooms as China's branded hotel penetration increases from 40% to 70%, providing low-teens annual growth potential. Market share gains from inefficient state-owned competitors and upscale repositioning should drive margin expansion. The valuation disconnect is striking - trading near 2020 levels despite doubled revenue and earnings, with enterprise value at $12 billion versus $19-23 billion for comparable international peers despite similar EBITDA generation. This combination of sustainable competitive advantages, clear growth trajectory, and significant valuation discount creates an attractive risk-adjusted opportunity.

Pitch Summary:
BYD, the global leader in electric and hybrid vehicles, delivered 4.3 million units in 2024, not far from Tesla's 1.8 million and Toyota's 10 million, a remarkable acceleration from just 600,000 units in 2021. The company's competitive advantage stems from something rare in the automotive industry: deep vertical integration. While traditional manufacturers rely on fragmented supplier networks, BYD designs and manufactures key components in-house, from batteries to semiconductors. This isn't just about control; it's about fundamental cost advantage. As the world's largest mobile battery maker before entering autos, founder Wang Chuan-Fu envisioned EVs as "batteries on wheels" and built the company to exploit the structural simplicity of electric drivetrains, which require fewer than 50 components versus 1,200+ in internal combustion engines. The result is a 15-25% cost advantage over legacy automakers, allowing BYD to offer compelling value while maintaining margins not far from Toyota levels. The company commands 35% of China's EV market and 30% of its battery market, with successful expansion underway in South Asia and Latin America. Europe is next. The stock trades at over 7% normalized earnings yield despite double-digit growth potential, as the stock price consolidated while price competition temporarily pressures margins.

BSD Analysis:
The manager builds a strong bull case for BYD based on its unique vertical integration strategy and cost advantages in the EV market. The company's evolution from battery manufacturer to automotive leader provides structural cost advantages of 15-25% over traditional automakers, enabling competitive pricing while maintaining healthy margins. BYD's remarkable scale acceleration from 600,000 to 4.3 million units demonstrates execution capability and market acceptance. The dual market leadership in both EVs (35% China share) and batteries (30% share) creates synergistic advantages and diversified revenue streams. Geographic expansion into South Asia, Latin America, and upcoming Europe entry provides substantial growth runway beyond the domestic market. At over 7% normalized earnings yield with double-digit growth potential, the valuation appears attractive despite temporary margin pressure from price competition. The combination of structural cost advantages, market leadership, geographic expansion opportunities, and compelling valuation supports the bullish investment thesis.

Pitch Summary:
Alibaba is one of China's digital infrastructure backbones, a $150 billion revenue company that has evolved from Jack Ma's startup into the dominant force in Chinese e-commerce and cloud computing. The company commands 45% of China's e-commerce market through Taobao and Tmall, platforms that connect 10 million merchants with one billion customers. After years of competitive pressure from JD.com and Pinduoduo, Alibaba's market position has stabilized, and its scale enables high-margin operations while taking less from merchants than competitors. The regulatory environment has shifted dramatically since 2023, with Beijing moving from crackdown to active support, explicitly endorsing Alibaba's aggressive capital return plans of 117 billion CNY in 2025 backed by 500 billion CNY in net cash. What makes Alibaba particularly compelling is how its cloud business is accelerating. Holding an estimated 30% of China's cloud market, the company seamlessly integrates its Qwen LLM into the e-commerce ecosystem, attracting businesses to its cloud infrastructure while delivering practical AI applications. With 100,000 corporate clients already using Qwen, and China's cloud penetration still far below Western markets, the runway is substantial. The stock trades at an 8% earnings yield despite this combination of stable e-commerce cash generation and high-growth cloud potential.

BSD Analysis:
The manager presents a compelling bull case for Alibaba centered on its dominant market position and AI-driven cloud acceleration. With 45% market share in Chinese e-commerce and stabilizing competitive dynamics, Alibaba has demonstrated resilient fundamentals while trading at attractive valuations. The regulatory shift from crackdown to support, evidenced by Beijing's endorsement of aggressive capital returns, removes a key overhang that has pressured the stock. The cloud business acceleration through Qwen LLM integration represents a significant catalyst, with 100,000 corporate clients already adopted and substantial runway given China's low cloud penetration versus Western markets. At an 8% earnings yield, the valuation appears compelling for a company generating stable e-commerce cash flows while capturing high-growth cloud opportunities. The combination of market leadership, regulatory tailwinds, AI monetization, and attractive valuation multiples supports the manager's bullish thesis.

Pitch Summary:
Upwork is a leading platform for freelance jobs. Its customers include not just small but also larger companies such as Microsoft and AirBnB. Acquisitions have strengthened the company's position in the software sector; in the long term, it wants to turn its customer relationships into an integrated management platform for external employees. Upwork has seen high demand for freelancers with AI expertise; the company is already profitable and is traded at an expected P/E ratio of 14.6.

BSD Analysis:
Upwork is successfully navigating the evolving workforce landscape in 2026, focusing on its high-margin "Enterprise" business and the integration of AI-driven tools to match freelancers with complex corporate projects. The company has moved decisively toward sustained GAAP profitability, leveraging its "Work-from-Anywhere" moat to capture a larger share of the global knowledge economy. Management is prioritizing the expansion of its "full-suite" platform services, including payroll and compliance, to become a one-stop-shop for global talent acquisition. While competition from traditional staffing firms and new AI platforms remains a factor, Upwork’s massive data set and established reputation provide a significant barrier to entry. Investors are looking for continued margin expansion as the firm leverages its AI "Umbrella" to improve search efficiency and customer retention.

Pitch Summary:
Umicore, which was sold in 2021 at prices of over EUR 40, was purchased back at EUR 14. The turnaround seems to be working. Umicore recycles sometimes critical metals, whose prices have increased a lot recently. Similarly, the company also intends to sell its gold holdings (EUR 410 million).

BSD Analysis:
Umicore is currently navigating a transitional period in 2026, having recently launched a strategic sale and lease-back of its permanent gold inventories to unlock significant capital for its battery materials division. The company's 2025 full-year results were characterized by guidance upgrades and a focus on stabilizing its position in the competitive EV battery supply chain. While the share price has experienced some near-term pressure, trading around €18.08, the firm’s leadership in recycling and catalyst technologies provides a robust structural moat. Management is prioritizing capital efficiency and strategic partnerships to navigate the volatile lithium-ion market and the shift toward next-generation battery chemistries. For investors, Umicore represents a specialized play on the circular economy and the long-term electrification of the automotive industry.

Pitch Summary:
The activist investor Elliott Management is pushing PepsiCo towards a strategic re-alignment of its business, including re-franchising the filling business and portfolio adjustments, with the aim of significant improvements in internal efficiency and profit margins. These measures signal tremendous price potential due to the reassessment of the share value, even if PepsiCo is already a financially stable dividend aristocrat that has reliably increased its distributions over five decades.

BSD Analysis:
PepsiCo is embarking on an aggressive productivity and margin expansion agenda for 2026, with CEO Ramon Laguarta targeting organic revenue growth of 2% to 4%. The company expects to deliver at least 100 basis points of core operating margin expansion over the next three years through massive investments in automation, digitalization, and supply chain optimization. While global minimum tax regulations will pose a headwind, core EPS is projected to rise by 7% to 9% when excluding these tax impacts. Management’s focus on "permissible and functional" offerings is designed to capture the growing consumer demand for healthier, simple-ingredient snacks and beverages. With 53 consecutive years of dividend increases, PepsiCo remains a premier defensive staple for investors looking for a blend of record productivity and reliable shareholder returns.

Pitch Summary:
KGHM Polska Miedz is the only notable copper and silver producer in Europe, hence its strategic importance to the development of digital infrastructure in an era of deglobalization. KGHM is the second-largest silver producer after Fresnillo (Mexico). There has been a structural deficit in silver production for years.

BSD Analysis:
KGHM, the Polish copper giant, began 2026 with a 2.7% increase in copper output, reaching 60,500 tonnes in January alone. While production is scaling, the company faced a slight 2.5% decrease in actual sales volume for the same period, highlighting a temporary mismatch between supply and global logistics. Analyst recommendations remain mixed, with 7 buy ratings and 5 sell ratings, reflecting a broader debate over the company’s cost structure and the volatility of the copper market. Management is prioritizing the development of its deep-level mining assets and international projects to secure a long-term supply of critical metals for the energy transition. For investors, KGHM offers a direct, high-leverage play on global copper prices, though operational efficiency in its legacy Polish mines remains a critical metric to watch.